Austin Private Wealth LLC Buys 51 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Austin Private Wealth LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,135 shares of the healthcare conglomerate’s stock after acquiring an additional 51 shares during the period. Austin Private Wealth LLC’s holdings in UnitedHealth Group were worth $598,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Robbins Farley bought a new stake in UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC increased its stake in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in UnitedHealth Group during the first quarter worth approximately $35,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Barclays assumed coverage on UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price on the stock. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $579.33.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 0.3 %

UNH stock traded up $1.60 during mid-day trading on Thursday, reaching $494.70. 3,805,551 shares of the company traded hands, compared to its average volume of 4,097,774. The stock has a market cap of $456.08 billion, a price-to-earnings ratio of 20.70, a P/E/G ratio of 1.34 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The firm’s 50 day moving average price is $503.10 and its 200 day moving average price is $518.61.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same quarter in the previous year, the business earned $5.34 EPS. The company’s revenue was up 14.1% compared to the same quarter last year. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.